CRT 2025
Power Break Symposium
Ziad Ali, MD, DPhil
Director
DeMatteis Cardiovascular Institute
Columbia University
Roslyn, New York, United States
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); Abiomed: Grant/Research Support (Ongoing); Acist Medical: Grant/Research Support (Ongoing); AstraZeneca: Consulting Fees (e.g., advisory boards) (Ongoing); Cardiovascular Systems Inc: Grant/Research Support (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Elucid BioImaging: Stock-privately held company (Ongoing); NIH: Grant/Research Support (Ongoing); Opsens: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips; Abbott: Grant/Research Support (Ongoing); SpectraWAVE, Inc: Stock-privately held company (Ongoing); Teleflex: Grant/Research Support (Ongoing)
Robert Stoler, MD
Director-Cardiac Catheterization Lab. Co-Chief of Cardiology
Baylor Heart & Vascular Hospital; Baylor University Medical Center
Dallas, Texas, United States
Disclosure(s): Biotronix: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)